Physician profile
Blake E Pritchett
NPI 1992446454
$5,157.12
in general payments reported to CMS, 2019-2025
15 companies · $5,157 in 2025
The $5,157 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $5,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,789 · Travel and Lodging: $2,368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,789.23 |
| Travel and Lodging | $2,367.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,797.57 | 2025 | |
| Medline Industries Lp | $1,403.51 | 2025 | |
| Stryker Corporation | $1,238.66 | 2025 | Augment Injectable, Hoffmann, Variax |
| Depuy Synthes Sales INC. | $171.48 | 2025 | Na |
| Orthofix Medical, INC. | $157.50 | 2025 | Truelok |
| Amgen INC. | $126.90 | 2025 | Krystexxa |
| Paragon 28, INC. | $66.80 | 2025 | Phantom Fibula Nail |
| Radius Health, INC. | $33.87 | 2025 | Tymlos |
| Blue Surgical LLC | $30.91 | 2025 | |
| Smith+Nephew, INC. | $27.80 | 2025 | Stravix |
| Averitas Pharma INC. | $27.33 | 2025 | Qutenza |
| Avita Medical Americas, LLC | $21.94 | 2025 | Recell, Cohealyx, Permeaderm |
| Medtronic, INC. | $20.86 | 2025 | Inpen Smart Insulin Delivery System |
| Integra Lifesciences Corporation | $16.06 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mimedx Group, INC. | $15.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Pritchett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.